Jocelyne Chiquette

3.4k total citations
39 papers, 542 citations indexed

About

Jocelyne Chiquette is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Jocelyne Chiquette has authored 39 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 19 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Jocelyne Chiquette's work include BRCA gene mutations in cancer (35 papers), Global Cancer Incidence and Screening (14 papers) and Genomics and Rare Diseases (5 papers). Jocelyne Chiquette is often cited by papers focused on BRCA gene mutations in cancer (35 papers), Global Cancer Incidence and Screening (14 papers) and Genomics and Rare Diseases (5 papers). Jocelyne Chiquette collaborates with scholars based in Canada, France and United Kingdom. Jocelyne Chiquette's co-authors include Michel Dorval, Jacques Simard, Marie Plante, Rachel Laframboise, Bernard Lespérance, Louise Provencher, Peter J. Bridge, Christine Desbiens, Caroline Diorio and Paul Bessette and has published in prestigious journals such as International Journal of Cancer, Cancer Epidemiology Biomarkers & Prevention and BMC Cancer.

In The Last Decade

Jocelyne Chiquette

37 papers receiving 534 citations

Peers

Countries citing papers authored by Jocelyne Chiquette

Since Specialization

Citations

This map shows the geographic impact of Jocelyne Chiquette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyne Chiquette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyne Chiquette more than expected).

Fields of papers citing papers by Jocelyne Chiquette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelyne Chiquette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyne Chiquette. The network helps show where Jocelyne Chiquette may publish in the future.

Co-authorship network of co-authors of Jocelyne Chiquette

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelyne Chiquette. A scholar is included among the top collaborators of Jocelyne Chiquette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelyne Chiquette. Jocelyne Chiquette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic discrimination in insurance and employment based on personalized risk stratification for breast cancer screening 2025 ·Frontiers in Genetics ·(unknown), (unknown), Kristina M. Blackmore, Jocelyne Chiquette, Éric Demers, Michel Dorval, (unknown), Hermann Nabi, Nora Pashayan, Penny Soucy, (unknown), (unknown), Bartha Maria Knoppers, Anna M. Chiarelli, Jacques Simard, (unknown)	2
2	Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study 2024 ·Cancer Medicine ·Josée Savard, (unknown), (unknown), Aude Caplette‐Gingras, Jocelyne Chiquette, Michel Dorval	2
3	Canadian Healthcare Professionals’ Views and Attitudes toward Risk-Stratified Breast Cancer Screening 2023 ·Journal of Personalized Medicine ·Julie Lapointe, (unknown), (unknown), Michel Dorval, Nora Pashayan, Jocelyne Chiquette, (unknown), (unknown), (unknown), Jennifer D. Brooks, Meghan J. Walker, Kristina M. Blackmore, Yann Joly, Bartha Maria Knoppers, Anna M. Chiarelli, Jacques Simard, Hermann Nabi	4
4	Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings 2021 ·BMC Medical Genomics ·(unknown), Michel Dorval, (unknown), Jocelyne Chiquette, (unknown), (unknown), Vincent Fradet, Yann Joly, Hermann Nabi	11
5	Survey of palliative care providers’ needs, perceived roles, and ethical concerns about addressing cancer family history at the end of life 2020 ·Palliative & Supportive Care ·(unknown), (unknown), (unknown), Yann Joly, Pierre Gagnon, (unknown), Jocelyne Chiquette, Bruno Gagnon, Louis Roy, Vasiliki Bitzas, Hermann Nabi, Michel Dorval	1
6	A Randomized Double-Blind Placebo-Controlled Trial of the Effect of Vitamin D3 Supplementation on Breast Density in Premenopausal Women 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Jacques Brisson, Sylvie Bérubé, Caroline Diorio, Benoı̂t Mâsse, Julie Lemieux, Thierry Duchesne, Edgar Delvin, Reinhold Vieth, Martin J. Yaffe, Jocelyne Chiquette	13
7	Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone‐Based Peer Support Intervention 2017 ·Journal of Genetic Counseling ·(unknown), (unknown), Lynn R. Gauthier, Jocelyne Chiquette, Michel Dorval	13
8	No Evidence of Excessive Cancer Screening in Female Noncarriers from BRCA1/2 Mutation–Positive Families 2017 ·Current Oncology ·(unknown), (unknown), William D. Foulkes, Pavel Hamet, Jacques Simard, Nora Wong, (unknown), Jocelyne Chiquette, Michel Dorval	3
9	Issues related to family history of cancer at the end of life: a palliative care providers’ survey 2017 ·Familial Cancer ·(unknown), (unknown), Pierre Gagnon, (unknown), Jocelyne Chiquette, Bruno Gagnon, Louis Roy, (unknown), Yann Joly, Michel Dorval	11
10	Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing? 2016 ·Familial Cancer ·(unknown), Jocelyne Chiquette, (unknown), Jacques Simard, Michel Dorval	5
11	Is Clinical Breast Examination Important for Breast Cancer Detection? 2016 ·Current Oncology ·Louise Provencher, Jean‐Charles Hogue, Christine Desbiens, Brigitte Poirier, Éric Poirier, Dominique K. Boudreau, (unknown), Caroline Diorio, Nathalie Duchesne, Jocelyne Chiquette	63
12	Development of a Tool to Guide Parents Carrying a BRCA1/2 Mutation Share Genetic Results with Underage Children 2016 ·Journal of Cancer Education ·(unknown), (unknown), (unknown), (unknown), Jocelyne Chiquette, Michel Dorval	7
13	Recommendations on Breast Cancer Screening and Prevention in the Context of Implementing Risk Stratification: Impending Changes to Current Policies 2016 ·Current Oncology ·(unknown), (unknown), Francine Borduas, Jocelyne Chiquette, Caroline Diorio, Nathalie Duchesne, (unknown), (unknown), William D. Foulkes, Nicole Gervais, Lucie Lalonde, Bernard Lespérance, Sarkis Meterissian, Louise Provencher, Jean‐Baptiste Richard, (unknown), Isabelle Trop, Nan Soon Wong, (unknown), Jacques Simard	33
14	A focus group study on breast cancer risk presentation: one format does not fit all 2012 ·European Journal of Human Genetics ·Michel Dorval, (unknown), Jocelyne Chiquette, Gord Glendon, Christine M. Maugard, (unknown), Seema Panchal, Jacques Simard	21
15	Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec 2011 ·European Journal of Human Genetics ·(unknown), Michel Dorval, (unknown), (unknown), (unknown), Jocelyne Chiquette, (unknown), Christine Lasset, Claude Picard, Marie Plante, Jacques Simard, Claire Julian‐Reynier	13
16	Self-reported mammography use following BRCA1/2 genetic testing may be overestimated 2011 ·Familial Cancer ·(unknown), (unknown), Jocelyne Chiquette, Christine Desbiens, Jacques Simard, Michel Dorval	15
17	Effect of the Women's Health Initiative Study Publication on Hormone Replacement Therapy Use among Women Who Have Undergone BRCA1/2 Testing 2007 ·Cancer Epidemiology Biomarkers & Prevention ·Michel Dorval, (unknown), Marie Plante, Jocelyne Chiquette, Michel Gaudet, Jacques Simard	4
18	Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high‐risk non BRCA1/2 French Canadian breast and ovarian cancer families 2007 ·International Journal of Cancer ·Sylvie Desjardins, Pascal Belleau, Yvan Labrie, Geneviève Ouellette, Paul Bessette, Jocelyne Chiquette, Rachel Laframboise, (unknown), Bernard Lespérance, (unknown), Marie Plante, (unknown), (unknown)	17
19	No Evidence of BRCA1/2 Genomic Rearrangements in High-Risk French-Canadian Breast/Ovarian Cancer Families 2006 ·Genetic Testing ·(unknown), (unknown), (unknown), C. Samson, Paul Bessette, Jocelyne Chiquette, Rachel Laframboise, (unknown), Bernard Lespérance, (unknown), Marie Plante, Louise Provencher, (unknown), David E. Goldgar, Peter J. Bridge, Jacques Simard	41
20	Partnering in Oncogenetic Research – The INHERIT BRCAs Experience: Opportunities and Challenges 2006 ·Familial Cancer ·Denise Avard, Peter J. Bridge, Lucie M. Bucci, Jocelyne Chiquette, Michel Dorval, Francine Durocher, Doug Easton, Béatrice Godard, David E. Goldgar, Bartha Maria Knoppers, Rachel Laframboise, Bernard Lespérance, Marie Plante, Sean V. Tavtigian, Hélène Vézina, Brenda J. Wilson, (unknown), (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact